Life-Saving Treatments for Spinal Muscular Atrophy
Victor Diego Armengol(King Saud bin Abdulaziz University for Health Sciences), Bhaskar Roy(Yale University), Robert C. Griggs(University of Rochester), Maggie C. Walter(Ludwig-Maximilians-Universität München), Damjan Osredkar(University of Ljubljana), Kayoko Saito, C. Marini-Bettolo(King Saud bin Abdulaziz University for Health Sciences), Gwendoline Kandawasvika(University of Zimbabwe), Jin‐Hong Shin(Inje University Busan Paik Hospital), Hui Xiong(Peking University), Susana Quijano‐Roy(King Saud bin Abdulaziz University for Health Sciences), Michelle A. Farrar(Sydney Children's Hospital), Inmaculada Pitarch Castellano(King Saud bin Abdulaziz University for Health Sciences), Jithangi Wanigasinghe(King Saud bin Abdulaziz University for Health Sciences), Ali Alshehri(King Saud bin Abdulaziz University for Health Sciences), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Juan F. Vázquez‐Costa(King Saud bin Abdulaziz University for Health Sciences), Nina Barišić(University Hospital Centre Zagreb), Ahmad Abulaban(King Saud bin Abdulaziz University for Health Sciences), Gerald Pfeffer(University of Calgary), Flávia Piazzon(King Saud bin Abdulaziz University for Health Sciences), Basil T. Darras, Claudia Castiglioni(King Saud bin Abdulaziz University for Health Sciences), Jean K. Mah(University of Calgary), Satish V. Khadilkar(King Saud bin Abdulaziz University for Health Sciences), Guenther Bernert(King Saud bin Abdulaziz University for Health Sciences), Yin‐Hsiu Chien(National Taiwan University Hospital)
Cited by 19
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Clinical trial in duchenne dystrophy. I. The design of the protocol
|Muscle & Nerve|1981|563